EyePoint Pharmaceuticals
(NASDAQ:EYPT)
$3.29
-0.03[-0.90%]
Last update: 1:55PM (Delayed 15-Minutes)
Get Real Time Here
Day Range3.28 - 3.452 Wk Range3.26 - 14.41Open / Close3.34 / -Float / Outstanding20.4M / 34.1M
Vol / Avg.72.4K / 127.1KMkt Cap112.1MP/E-50d Avg. Price5.77
Div / Yield-Payout Ratio-Total Float20.4MEPS-0.49

EyePoint Pharmaceuticals Stock (NASDAQ:EYPT), Quotes and News Summary

EyePoint Pharmaceuticals Stock (NASDAQ: EYPT) stock price, news, charts, stock research, profile.

Loading...
Day Range3.28 - 3.452 Wk Range3.26 - 14.41Open / Close3.34 / -Float / Outstanding20.4M / 34.1M
Vol / Avg.72.4K / 127.1KMkt Cap112.1MP/E-50d Avg. Price5.77
Div / Yield-Payout Ratio-Total Float20.4MEPS-0.49
Newsfile - 3 days ago
Newsfile - 4 days ago
Newsfile - 6 days ago
Newsfile - Nov 20, 2022, 8:21AM
Newsfile - Nov 18, 2022, 6:34PM
Newsfile - Nov 10, 2022, 6:28PM
Newsfile - Nov 9, 2022, 6:19PM
Newsfile - Nov 7, 2022, 5:35PM
Newsfile - Nov 6, 2022, 8:21AM
Newsfile - Nov 4, 2022, 6:34PM
Newsfile - Oct 30, 2022, 8:21PM
Newsfile - Oct 28, 2022, 6:34PM
InvestorPlace - Jul 12, 2022, 6:00AM
Sector: Health Care.Industry: Pharmaceuticals
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.700-0.490 0.2100
REV10.640M10.012M-628.000K
Q2 2022Est.ActualSurprise
EPS-0.520-0.520 0.0000
REV10.870M11.565M695.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy EyePoint Pharmaceuticals (EYPT) stock?

A

You can purchase shares of EyePoint Pharmaceuticals (NASDAQ: EYPT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are EyePoint Pharmaceuticals's (EYPT) competitors?

Q

What is the target price for EyePoint Pharmaceuticals (EYPT) stock?

A

The latest price target for EyePoint Pharmaceuticals (NASDAQ: EYPT) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 52.00 expecting EYPT to rise to within 12 months (a possible 1480.55% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for EyePoint Pharmaceuticals (EYPT)?

A

The stock price for EyePoint Pharmaceuticals (NASDAQ: EYPT) is $3.29 last updated Today at November 28, 2022, 6:55 PM UTC.

Q

Does EyePoint Pharmaceuticals (EYPT) pay a dividend?

A

There are no upcoming dividends for EyePoint Pharmaceuticals.

Q

When is EyePoint Pharmaceuticals (NASDAQ:EYPT) reporting earnings?

A

EyePoint Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 2, 2022.

Q

Is EyePoint Pharmaceuticals (EYPT) going to split?

A

There is no upcoming split for EyePoint Pharmaceuticals.

Q

What sector and industry does EyePoint Pharmaceuticals (EYPT) operate in?

A

EyePoint Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.